Skip to content
HowShorted

PTC Therapeutics, Inc. short interest in 2020

In 2020, PTC Therapeutics, Inc.'s disclosed short interest ran from 5.43% of shares outstanding on 15 Jan 2020 to 6.92% on 31 Dec 2020, a change of +1.49 percentage points. The year's high was 9.28% on 14 Aug 2020 and its low 5.43% on 15 Jan 2020, averaging 7.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.21 days on 30 Oct 2020. Full history: PTC Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PTC Therapeutics, Inc. in 2020

2020 in figures

Start of year
5.43% (15 Jan 2020)
End of year
6.92% (31 Dec 2020)
Change
+1.49 pp
High
9.28% (14 Aug 2020)
Low
5.43% (15 Jan 2020)
Average
7.15%
Highest days to cover
14.21 (30 Oct 2020)
SEC filings marked
9

Every report in 2020

PTC Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20205.43%4.97results (8-K)
31 Jan 20205.60%4.85
14 Feb 20205.64%3.28
28 Feb 20206.07%3.85
13 Mar 20206.55%3.7710-K filed, results (8-K)
31 Mar 20207.30%4.11
15 Apr 20207.05%7.24
30 Apr 20206.41%5.6510-Q filed, results (8-K)
15 May 20207.10%6.29
29 May 20207.00%10.24
15 Jun 20207.77%7.85
30 Jun 20208.35%7.64
15 Jul 20208.70%9.92
31 Jul 20208.17%6.78
14 Aug 20209.28%4.4610-Q filed, results (8-K)
31 Aug 20208.42%13.74
15 Sep 20207.33%10.88
30 Sep 20207.64%12.53
15 Oct 20207.38%12.60
30 Oct 20206.61%14.2110-Q filed, results (8-K)
13 Nov 20206.87%9.72
30 Nov 20206.83%13.76
15 Dec 20207.20%9.30
31 Dec 20206.92%11.30

See also: PTC Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.